Oxonica And Croda Form Partnership To Drive Oxonica's UV Absorber Optisol(TM) Into The Global Cosmetics Market |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Oxonica Limited
7 Begbroke Science Park
Yarnton, Kidlington , Oxford, OX5 1PF
United Kingdom
Press release date: December 15, 2005
Oxonica plc, a leading European nanotechnology group, is pleased to announce that it has signed an exclusive agreement with Croda, a global speciality chemicals group, to distribute Oxonica's Optisol(TM) UV absorber into the international personal care market.
Optisol(TM) was launched in 2004, and is currently incorporated within the Boots Soltan Facial range. Over the past year, Oxonica has focused on increasing the awareness of Optisol(TM) within the major cosmetic houses, and to this end, has achieved several successful evaluations as well as a nomination for "best new technology" at the HBA awards ceremony in New York in September 2005. The partnership with Croda is geared towards crystallising some of these early evaluations.
Croda will provide its sales channel and technical expertise to broaden the commercialisation of Optisol(TM) across a wider customer base, with an initial focus on the Americas, Europe and Australia. Croda's global marketing network will allow a greater market penetration of the innovative Optisol(TM). Oxonica will work closely with Croda to provide technical and product development support.
Dr Kevin Matthews, Oxonica's CEO, said: "Oxonica is delighted to announce its commercial partnership with Croda, in a deal that makes Optisol(TM) available to the global cosmetics market worldwide. At our admission to AIM in July, we said we would look for partner relationships to broaden our marketing and sales outlets and this agreement with Croda successfully demonstrates that strategy." Dr Keith Layden, President of Enterprise Technology at Croda, said: "Croda has been supplying high quality speciality chemicals to the personal care market for over 80 years and the company's focus has been on the development of ever more sophisticated ingredients and actives covering all aspects of personal care. The addition of Optisol(TM) to our portfolio will allow us to offer our customers ground-breaking improvements in the performance of sunscreens, skincare and cosmetics"
David Browning, Business Director responsible for the commercialisation of Optisol(TM), commented: "The technology was developed in association with the University of Oxford. Optisol(TM) improves protection against exposure to sunlight and its unique technology acts to stabilise formulations and components, including vitamins and plant extracts, in a wide variety of cosmetics." For further information please contact:
Internal PR Contact Sonia Bouzid sonia.bouzid@oxonica.com +44 1865 856 728 External PR Contact Nigel Robson
Vortex PR Island House, Forest Road, Forest, Guernsey GY8 0AB, Great Britain Tel +44 1481 233080, Fax +44 1481 233082 Mobile +44 7766 705866
|
|
|
|
|
|
|
|
|
|
|
| 
